Anna Brown

London, United Kingdom

Reporter at Endpoints News

Featured in: Favicon

endpts.com Favicon

newsbreak.com Favicon

bioprocessintl.com Favicon

invesbrain.com Favicon

pewresearch.org Favicon

theflorala.com

Articles

Schott Pharma’s €100M+ Hungary expansion; Antheia’s $56M Series C raise

3 days ago | endpoints.news | Anna Brown

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Schott Pharma is Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Lilly makes a move for long-acting incretins in tech deal with Swedish biotech

4 days ago | endpoints.news | Anna Brown

Eli Lilly has tapped Camurus in a deal worth up to $870 million for its drug delivery technology to develop four long-acting incretin candidates. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Agenus quickly exits CDMO business by selling assets to Zydus for $75M upfront

5 days ago | endpoints.news | Anna Brown

Agenus is divesting its biologics CDMO business, which it launched only six months ago, to Indian drugmaker Zydus Lifesciences … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Large pharma companies spell out reasons why tariffs will harm US investments

1 week ago | endpts.com | Anna Brown

The first wave of biopharma comments on industry-specific tariffs is here. As of Thursday morning, just over 300 of at least 950 public comments have … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

1 week ago | endpts.com | Anna Brown

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Sanofi is Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

1 week ago | endpts.com | Anna Brown

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of semaglutide, as comments for the Department of … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA rejects Savara’s rare lung disease drug over limited manufacturing data

1 week ago | endpts.com | Anna Brown

The FDA has rejected Savara’s application for its rare lung disease candidate over insufficient chemistry, manufacturing and controls data, the clinical-stage biotech said Tuesday. … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
CHMP clears path for GSK’s Blenrep relaunch, recommends four other drugs

2 weeks ago | endpts.com | Anna Brown

GSK, Roche and SpringWorks Therapeutics were among those that secured a positive opinion for new drugs from the European Medicines Agency’s human medicines committee … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA names acting head of inspections; J&J again advocates for tax policies as alternative to tariffs

2 weeks ago | endpts.com | Anna Brown

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. The FDA has Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

2 weeks ago | endpts.com | Anna Brown

A little-known — but legal — trade principle is likely to be on pharma companies’ radars as they search for strategies to reduce exposure to President Donald … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.